Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    LifeStance Health Group I...

    NASDAQ: LFST · Real-Time Price · USD
    4.77
    -0.22 (-4.41%)
    At close: Jul 02, 2025, 3:59 PM

    LifeStance Health Statistics

    Share Statistics

    LifeStance Health has 388.88M shares outstanding. The number of shares has increased by 1.63% in one year.

    Shares Outstanding

    n/a
    		 388.88M

    Shares Change (YoY)

    n/a
    		 1.63%

    Shares Change (QoQ)

    n/a
    		 1.12%

    Owned by Institutions (%)

    n/a
    		 88.89%

    Shares Floating

    n/a
    		 116.5M

    Failed to Deliver (FTD) Shares

    n/a
    		 319

    FTD / Avg. Volume

    n/a
    		 0.02%

    Short Selling Information

    The latest short interest is 9.26M, so 2.38% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 9.26M

    Short % of Shares Out

    n/a
    		 2.38%

    Short % of Float

    n/a
    		 10.74%

    Short Ratio (days to cover)

    n/a
    		 6.09

    Valuation Ratios

    The PE ratio is -48.64 and the forward PE ratio is 129.25. LifeStance Health's PEG ratio is 0.69.

    PE Ratio

    n/a
    		 -48.64

    Forward PE

    n/a
    		 129.25

    PS Ratio

    n/a
    		 2.23

    Forward PS

    n/a
    		 1

    PB Ratio

    n/a
    		 1.93

    P/FCF Ratio

    n/a
    		 32.61

    PEG Ratio

    n/a
    		 0.69
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for LifeStance Health.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.37, with a Debt / Equity ratio of 0.34.

    Current Ratio

    n/a
    		 1.37

    Quick Ratio

    n/a
    		 1.37

    Debt / Equity

    n/a
    		 0.34

    Debt / EBITDA

    n/a
    		 12.17

    Debt / FCF

    n/a
    		 5.66

    Interest Coverage

    n/a
    		 -1.19

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $166,021.23

    Profits Per Employee

    n/a
    		 $-7,623.49

    Employee Count

    n/a
    		 7,535

    Asset Turnover

    n/a
    		 0.59

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -170K

    Effective Tax Rate

    n/a
    		 0.3%

    Stock Price Statistics

    The stock price has increased by -5.92% in the last 52 weeks. The beta is 1.22, so LifeStance Health's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.22

    52-Week Price Change

    n/a
    		 -5.92%

    50-Day Moving Average

    n/a
    		 5.76

    200-Day Moving Average

    n/a
    		 6.9

    Relative Strength Index (RSI)

    n/a
    		 31.41

    Average Volume (20 Days)

    n/a
    		 1,917,544

    Income Statement

    In the last 12 months, LifeStance Health had revenue of 1.25B and earned -57.44M in profits. Earnings per share was -0.15.

    Revenue

    n/a
    		 1.25B

    Gross Profit

    n/a
    		 402.4M

    Operating Income

    n/a
    		 -31.61M

    Net Income

    n/a
    		 -57.44M

    EBITDA

    n/a
    		 39.87M

    EBIT

    n/a
    		 -31.08M

    Earnings Per Share (EPS)

    n/a
    		 -0.15
    Full Income Statement

    Balance Sheet

    The company has 154.57M in cash and 485.19M in debt, giving a net cash position of -330.62M.

    Cash & Cash Equivalents

    n/a
    		 154.57M

    Total Debt

    n/a
    		 485.19M

    Net Cash

    n/a
    		 -330.62M

    Retained Earnings

    n/a
    		 -818.29M

    Total Assets

    n/a
    		 2.1B

    Working Capital

    n/a
    		 97.25M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 107.26M and capital expenditures -21.57M, giving a free cash flow of 85.69M.

    Operating Cash Flow

    n/a
    		 107.26M

    Capital Expenditures

    n/a
    		 -21.57M

    Free Cash Flow

    n/a
    		 85.69M

    FCF Per Share

    n/a
    		 0.23
    Full Cash Flow Statement

    Margins

    Gross margin is 32.17%, with operating and profit margins of -2.53% and -4.59%.

    Gross Margin

    n/a
    		 32.17%

    Operating Margin

    n/a
    		 -2.53%

    Pretax Margin

    n/a
    		 -4.61%

    Profit Margin

    n/a
    		 -4.59%

    EBITDA Margin

    n/a
    		 3.19%

    EBIT Margin

    n/a
    		 -2.53%

    FCF Margin

    n/a
    		 6.85%

    Dividends & Yields

    LFST does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for LFST is $8.5, which is 78.2% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $8.5

    Price Target Difference

    n/a
    		 78.2%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 2.24

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist